212 top medical experts on Mesoblastic Nephroma across 28 countries and 18 U.S. states, including 80 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Mesoblastic Nephroma: A solid, unencapsulated tumor of the kidney composed of spindle mesenchymal cells that resemble fibroblasts or muscle cells. The homogeneous mass typically extends into the renal parenchyma and replaces most of the kidney. In most cases, mesoblastic nephroma is benign and occurs in the fetus or newborn, and rarely in the older child or the adult.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Complex and Mixed Neoplasms (2,455), Kidney Neoplasms (5,066).
  4. Clinical Trials ClinicalTrials.gov : at least 3 including 2 Recruiting


  

        

                    


    These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

  1. Laetsch, Theodore W   Pediatrics  Google Publications
    Department of Pediatrics and Simmons Comprehensive Cancer Center, University of Texas, Southwestern and Childrens Health, Dallas, TX.
    Physician 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $4,724, including $4,724 from  Bayer HealthCare Pharmaceuticals Inc.
    Subjects: Kidney Neoplasms; Nephroma, Mesoblastic; Fibrosarcoma; Gene Rearrangement; Immunohistochemistry
    Categories: Enzymology; Genetics
    Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors. (2018)
    Targeting NTRK fusions for the treatment of congenital mesoblastic nephroma. (2018)

  2. Davis, Jessica L   Anatomic Pathology & Clinical Pathology  Google Publications
    Department of Pathology, Oregon Health & Science University, Portland, Oregon, USA. Top Hospital
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 80.3/100
    Disclosed payments in 2021 from 6 biomedical companies, totalling $14,850, including $14,850 from  Bayer HealthCare Pharmaceuticals Inc.
    Subjects: Fibrosarcoma; Nephroma, Mesoblastic; Gene Rearrangement; Kidney Neoplasms; Immunohistochemistry; Neoplasms, Connective and Soft Tissue
    Categories: Genetics; Enzymology
    Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors. (2018)
    Mesenchymal neoplasms with NTRK and other kinase gene alterations. (2022)

  3. Rudzinski, Erin R   Anatomic Pathology & Clinical Pathology  Google Publications
    Department of Laboratories, Seattle Childrens Hospital, Seattle, Washington, USA.
    Physician 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $700, including $700 from  Bayer HealthCare Pharmaceuticals Inc.
    Subjects: Fibrosarcoma; Nephroma, Mesoblastic; Gene Rearrangement; Kidney Neoplasms; Immunohistochemistry; Neoplasms, Connective and Soft Tissue
    Categories: Genetics; Enzymology
    Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal Tumors. (2018)
    Mesenchymal neoplasms with NTRK and other kinase gene alterations. (2022)

  4. Jennings, Lawrence J   Molecular Genetic Pathology  Google Publications
    Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Childrens Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, IL - 60611. Top Hospital
    Physician 
    Medical school: Other (MD, 1993)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 86.9/100
    Disclosed payments from biomedical company (Personal Genome Diagnostics Inc) in 2021 for $500
    Subjects: Kidney Neoplasms; Nephroma, Mesoblastic; Biomarkers, Tumor; Exons; Mutation; Proto-Oncogene Proteins B-raf
    Categories: Genetics; Metabolism
    Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study. (2012)
    BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors. (2017)

  5. Perlman, Elizabeth J   Clinical Pathology/Laboratory Medicine  Google Publications
    Department of Pathology and Laboratory Medicine, Ann & Robert H. Lurie Childrens Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, IL - 60611. Top Hospital
    Physician 
    Subjects: Kidney Neoplasms; Nephroma, Mesoblastic; Biomarkers, Tumor; Exons; Mutation; Proto-Oncogene Proteins B-raf
    Categories: Genetics; Metabolism
    Mediators of receptor tyrosine kinase activation in infantile fibrosarcoma: a Children's Oncology Group study. (2012)
    BRAF exon 15 mutations in pediatric renal stromal tumors: prevalence in metanephric stromal tumors. (2017)

  6. Church, Alanna J   Molecular Genetic Pathology  Google Publications
    Department of Pathology, Boston Childrens Hospital and Harvard Medical School, Boston, MA, USA. Top Hospital
    Physician 
    Disclosed payments in 2021 from 2 biomedical companies, totalling $1,894.5, including $1,894.5 from  Bayer HealthCare Pharmaceuticals Inc.
    Subjects: Cell Cycle Proteins; Discoidin Domain Receptor 2; Fibrosarcoma; Kidney Neoplasms; Microtubule-Associated Proteins; Neoplasm Recurrence, Local
    Categories: Genetics; Diagnosis
    Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy. (2018)

  7. Behjati, Sam   Google Publications
    Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK. .
    Scientist 
    Subjects: Fibrosarcoma; Genes, erbB-1; Kidney Neoplasms; Nephroma, Mesoblastic; Proto-Oncogene Proteins B-raf
    Categories: Genetics
    Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. (2018)

  8. Wegert, Jenny  Google Publications
    Theodor-Boveri-Institute/Biocenter, Developmental Biochemistry, University of Wuerzburg, 97074, Wuerzburg, Germany.
    Scientist 
    Subjects: Fibrosarcoma; Genes, erbB-1; Kidney Neoplasms; Nephroma, Mesoblastic; Proto-Oncogene Proteins B-raf
    Categories: Genetics
    Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. (2018)

  9. Harris, Marian H   Anatomic Pathology  Google Publications
    Department of Pathology, Boston Childrens Hospital and Harvard Medical School, Boston, MA, USA. Top Hospital
    Physician 
    Subjects: Cell Cycle Proteins; Discoidin Domain Receptor 2; Fibrosarcoma; Kidney Neoplasms; Microtubule-Associated Proteins; Neoplasm Recurrence, Local
    Categories: Genetics; Diagnosis
    Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy. (2018)

  10. Srivastava, Tarak   Pediatric Nephrology   Google Publications
    University of Missouri, Kansas City, MO 64108, USA.
    Physician  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 72.7/100
    Disclosed payments from biomedical company (Travere Therapeutics, Inc.) in 2021 for $400
    Subjects: Hypercalcemia; Kidney Neoplasms; Nephroma, Mesoblastic; Parathyroid Hormone-Related Protein
    Categories: Complications; Metabolism; Etiology
    Parathyroid-hormone-related protein-mediated hypercalcemia in benign congenital mesoblastic nephroma. (2011)

  11. Dillon, Deborah A   Anatomic Pathology  Google Publications
    Department of Pathology, Brigham and Womens Hospital and Harvard Medical School, Boston, MA, USA. Top Hospital
    Physician 
    Medical school: Yale University School of Medicine (MD, 1992)
    Medicare Accepted
    Subjects: Cell Cycle Proteins; Discoidin Domain Receptor 2; Fibrosarcoma; Kidney Neoplasms; Microtubule-Associated Proteins; Neoplasm Recurrence, Local
    Categories: Genetics; Diagnosis
    Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy. (2018)

  12. Nardi, Valentina   Anatomic Pathology & Clinical Pathology  Google Publications
    Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Top Hospital
    Physician 
    Disclosed payments from biomedical company (Eli Lilly and Company) in 2021 for $2,400
    Subjects: Cell Cycle Proteins; Discoidin Domain Receptor 2; Fibrosarcoma; Kidney Neoplasms; Microtubule-Associated Proteins; Neoplasm Recurrence, Local
    Categories: Genetics; Diagnosis
    Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy. (2018)

  13. Pappo, Alberto S   Pediatric Hematology-Oncology  Google Publications
    Department of Oncology, St. Jude Childrens Research Hospital, Memphis, Tennessee.
    Physician  Case Reports 
    Disclosed payments in 2021 from 3 biomedical companies, totalling $5,650, including $2,800 from  Eli Lilly and Company
    Subjects: Antineoplastic Agents; Bone Neoplasms; Bone Remodeling; Kidney Neoplasms; Nephroma, Mesoblastic; Pyrazoles
    Categories: Drug Therapy; Therapeutic Use; Drug Effects
    Dramatic bone remodeling following larotrectinib administration for bone metastasis in a patient with TRK fusion congenital mesoblastic nephroma. (2018)

  14. Berry, Jeff L   Cardiovascular Disease  Google Publications
    Physician  Case Reports 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 97/100
    Disclosed payments in 2021 from 48 biomedical companies, totalling $925.82, including $223.33 from  CMS Imaging, Inc.
    Subjects: Kidney Diseases, Cystic; Kidney Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Nephroma, Mesoblastic; Tomography, X-Ray Computed
    Categories: Diagnosis; Methods
    Case report: Multimodality imaging of a cystic nephroma. (2013)

  15. Gupta, Arun   Family Medicine  Google Publications
    Physician  Case Reports 
    Medical school: Other (MD, 1980)
    Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 78.4/100
    Disclosed payments in 2021 from 46 biomedical companies, totalling $1,493.35, including $448.41 from  Janssen Pharmaceuticals, Inc
    Subjects: Kidney; Kidney Neoplasms; Nephroma, Mesoblastic
    Categories: Diagnosis; Pathology
    Cystic nephroma: a diagnostic dilemma. (2010)

  16. Khoury, Antoine E   Pediatric Urology  Google Publications
    Department of Urology, UC Irvine and Childrens Hospital of Orange County, Orange, CA.
    Physician  Case Reports 
    Disclosed payments from biomedical company (PALETTE LIFE SCIENCES, INC.) in 2021 for $1,575
    Subjects: Nephroma, Mesoblastic; Ultrasonography, Prenatal
    Categories: Diagnostic Imaging
    Papers presented at the fall 2020 Pediatric Urologic Oncology Work Group of the Societies of Pediatric Urology meetingPrenatally Diagnosed Solid Renal Mass. (2021)

  17. Koscielniak, Ewa    Google Publications
    Klinikum Stuttgart-Olgahospital, Stuttgart Cancer Center, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pediatrics 5 Oncology, Hematology, Immunology, 70174, Stuttgart, Germany.
    Physician 
    Subjects: Fibrosarcoma; Genes, erbB-1; Kidney Neoplasms; Nephroma, Mesoblastic; Proto-Oncogene Proteins B-raf
    Categories: Genetics
    Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. (2018)

  18. Kozakewich, Harry P   Cytopathology  Google Publications
    Department of Pathology, Boston Childrens Hospital and Harvard Medical School, Boston, MA, USA. Top Hospital
    Physician 
    Medical school: Other (MD, 1967)
    Medicare Accepted
    Subjects: Cell Cycle Proteins; Discoidin Domain Receptor 2; Fibrosarcoma; Kidney Neoplasms; Microtubule-Associated Proteins; Neoplasm Recurrence, Local
    Categories: Genetics; Diagnosis
    Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy. (2018)

  19. Nagasubramanian, Ramamoorthy   Pediatric Hematology-Oncology  Google Publications
    Nemours Childrens Hospital, Orlando, FL.
    Physician 
    Medical school: Other (MD, 1989)
    Medicare Accepted
    Subjects: Kidney Neoplasms; Nephroma, Mesoblastic
    Targeting NTRK fusions for the treatment of congenital mesoblastic nephroma. (2018)

  20. Caltharp, Shelley A   Anatomic Pathology & Clinical Pathology  Google Publications
    Childrens Healthcare of Atlanta and Emory University School of Medicine, Atlanta, United States. Top Hospital
    Physician 
    Medicare MIPS (Merit-based Incentive Payment System) rating: 85.6/100
    Disclosed payments from biomedical company (Roche Diagnostics Corporation) in 2021 for $16.51
    Subjects: Cyclin D1; Fibrosarcoma; Kidney Neoplasms; Nephroma, Mesoblastic; Oncogene Proteins, Fusion; Soft Tissue Neoplasms
    Categories: Pathology; Metabolism; Genetics
    Congenital mesoblastic nephroma: a study of 19 cases using immunohistochemistry and ETV6-NTRK3 fusion gene rearrangement. (2016)

Note:
  1. These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
  2. Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.
These expert listings are for individual use without a fee. Biotechs, Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and other organizations may use this only for quick evaluations (no downloads or screen scraping) to identify the top medical experts for recruiting, advisory panels, boards, and consulting. Please contact us for licensing, customized queries, feedback and questions.

);